We are live on ! Find out more
TC

Torno Capital Portfolio holdings

AUM $3.47B Turnover 87.5%
1-Year Est. Return 37.88%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+37.88%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$485M
AUM Growth
–
Cap. Flow
+$92.3M
Cap. Flow %
19.06%
Top 10 Hldgs %
46.02%
Holding
222
New
222
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.86%
2 Communication Services 5.36%
3 Consumer Staples 1.97%
4 Healthcare 1.22%
5 Consumer Discretionary 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TDS icon
76
PUT
Telephone and Data Systems
TDS
$3.96B
$1.1M 0.23%
+60,000
New +$1.11M
2023 Q4
0 quarters
MSI icon
77
Motorola Solutions
MSI
$77.1B
$1.1M 0.23%
+3,500
New +$1.06M
2023 Q4
0 quarters
DG icon
78
CALL
Dollar General
DG
$29.7B
$1.07M 0.22%
+7,900
New +$958K
2023 Q4
0 quarters
VKTX icon
79
CALL
Viking Therapeutics
VKTX
$3.33B
$1.06M 0.22%
+56,800
New +$743K
2023 Q4
0 quarters
IMVT icon
80
CALL
Immunovant
IMVT
$5.52B
$1.05M 0.22%
+25,000
New +$920K
2023 Q4
0 quarters
AMGN icon
81
CALL
Amgen
AMGN
$235B
$1.01M 0.21%
+3,500
New +$954K
2023 Q4
0 quarters
FLR icon
82
Fluor
FLR
$6.31B
$979K 0.2%
+25,000
New +$924K
2023 Q4
0 quarters
RARE icon
83
PUT
Ultragenyx Pharmaceutical
RARE
$1.45B
$956K 0.2%
+20,000
New +$775K
2023 Q4
0 quarters
NEE icon
84
CALL
NextEra Energy
NEE
$167B
$923K 0.19%
+15,200
New +$866K
2023 Q4
0 quarters
IMTX icon
85
PUT
Immatics
IMTX
$1.04B
$914K 0.19%
+86,800
New +$799K
2023 Q4
0 quarters
APLS icon
86
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$898K 0.19%
+15,000
New +$761K
2023 Q4
0 quarters
SKY icon
87
Champion Homes
SKY
$4.23B
$891K 0.18%
+12,000
New +$754K
2023 Q4
0 quarters
ANF icon
88
Abercrombie & Fitch
ANF
$6.45B
$882K 0.18%
+10,000
New +$712K
2023 Q4
0 quarters
REGN icon
89
Regeneron Pharmaceuticals
REGN
$81.6B
$878K 0.18%
+1,000
New +$823K
2023 Q4
0 quarters
DLO icon
90
CALL
dLocal
DLO
$4.31B
$872K 0.18%
+49,300
New +$882K
2023 Q4
0 quarters
AL icon
91
CALL
DELISTED
Air Lease Corp
AL
$839K 0.17%
+20,000
New +$757K
2023 Q4
0 quarters
SRPT icon
92
CALL
Sarepta Therapeutics
SRPT
$1.83B
$829K 0.17%
+8,600
New +$825K
2023 Q4
0 quarters
APD icon
93
CALL
Air Products & Chemicals
APD
$66.4B
$821K 0.17%
+3,000
New +$825K
2023 Q4
0 quarters
CERE icon
94
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$797K 0.16%
+18,800
New +$540K
2023 Q4
0 quarters
EDR icon
95
PUT
DELISTED
Endeavor Group Holdings, Inc.
EDR
$783K 0.16%
+33,000
New +$744K
2023 Q4
0 quarters
FLNA icon
96
CALL
Filana Therapeutics
FLNA
$35.2M
$763K 0.16%
+33,900
New +$716K
2023 Q4
0 quarters
IONS icon
97
PUT
Ionis Pharmaceuticals
IONS
$7.17B
$759K 0.16%
+15,000
New +$718K
2023 Q4
0 quarters
PHIN icon
98
CALL
Phinia Inc
PHIN
$2.14B
$757K 0.16%
+25,000
New +$670K
2023 Q4
0 quarters
PARA icon
99
CALL
DELISTED
Paramount Global Class B
PARA
$740K 0.15%
+50,000
New +$669K
2023 Q4
0 quarters
NTLA icon
100
CALL
Intellia Therapeutics
NTLA
$1.56B
$738K 0.15%
+24,200
New +$696K
2023 Q4
0 quarters

Similar funds

Torno Capital's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Torno Capital, which disclosed 222 positions worth $485M. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Sprott Uranium Miners ETF: 547,400 shares worth $26.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, followed by Communication Services and Consumer Staples.

  • Torno Capital's largest Q4 2023 buy was Sprott Uranium Miners ETF: 547,400 shares worth $26.4M.
  • Torno Capital's ten largest holdings make up 46% of its $485M portfolio in Q4 2023.
  • Torno Capital disclosed 222 positions in Q4 2023, its first 13F filing on record.

Based on Torno Capital's 13F filing for Q4 2023, filed 15 Feb 2024.